Ocular Therapeutix (OCUL) Gross Margin (2014 - 2026)
Ocular Therapeutix's quarterly Gross Margin came in at 87.68% in Q1 2026, up 11993.0% year-on-year from N/an in Q1 2025, and up 3864.93% quarter-over-quarter from 2.21% in Q4 2025.
Ocular Therapeutix has reported Gross Margin for 13 years, with the latest figure at 87.68% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 11993.0% year-over-year to 87.68%; the trailing twelve-month figure through Mar 2026 stood at 65.4% (up 1144.0% YoY), and the FY2025 full-year result was 3.79%, down 9497.0% from the prior year.
- Gross Margin for Q1 2026 stood at 87.68%, up from 2.21% in the prior quarter.
- The five-year high for Gross Margin was 92.81% in Q4 2022, with the low at 147.65% in Q4 2023.
- Average Gross Margin over 5 years is 45.57%, with a median of 85.56% recorded in 2025.
- Year-over-year, Gross Margin tumbled 24046 bps in 2023 and surged 24044 bps in 2024.
- Tracing OCUL's Gross Margin over 5 years: stood at 92.81% in 2022, then slumped by 259 bps to 147.65% in 2023, then surged by 163 bps to 92.8% in 2024, then sank by 98 bps to 2.21% in 2025, then jumped by 3865 bps to 87.68% in 2026.
- The last three Gross Margin figures came in at 87.68% (Q1 2026), 2.21% (Q4 2025), and 87.8% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 87.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.68% |
| Dec 31, 2025 | 2.21% |
| Sep 30, 2025 | 87.80% |
| Jun 30, 2025 | 85.56% |
| Mar 31, 2025 | -32.25% |
| Dec 31, 2024 | 92.80% |
| Sep 30, 2024 | 31.46% |
| Jun 30, 2024 | 90.82% |
| Mar 31, 2024 | 91.02% |
| Dec 31, 2023 | -147.65% |
| Sep 30, 2023 | 38.23% |
| Jun 30, 2023 | 26.56% |
| Mar 31, 2023 | 90.92% |
| Dec 31, 2022 | 92.81% |
| Sep 30, 2022 | 14.87% |
| Jun 30, 2022 | 90.58% |
| Mar 31, 2022 | 31.27% |
| Dec 31, 2021 | 91.00% |
| Sep 30, 2021 | 89.22% |
| Jun 30, 2021 | 28.39% |
| Mar 31, 2021 | -10.13% |
| Dec 31, 2020 | 341.12% |
| Sep 30, 2020 | -10.96% |
| Jun 30, 2020 | -292.16% |
| Mar 31, 2020 | -173.28% |
| Dec 31, 2019 | 765.96% |
| Sep 30, 2019 | -717.49% |
| Jun 30, 2019 | -1,011.54% |
| Mar 31, 2019 | -580.28% |
| Dec 31, 2018 | 76.79% |
| Sep 30, 2018 | 76.91% |
| Jun 30, 2018 | -33.80% |
| Mar 31, 2018 | -110.88% |
| Dec 31, 2017 | -85.42% |
| Sep 30, 2017 | -519.12% |
| Jun 30, 2017 | -1,459.82% |
| Mar 31, 2017 | -1,168.84% |
| Dec 31, 2016 | -1,149.51% |
| Sep 30, 2016 | 76.52% |
| Jun 30, 2016 | 76.19% |
| Mar 31, 2016 | 76.20% |
| Dec 31, 2015 | -820.05% |
| Sep 30, 2015 | -121.95% |
| Jun 30, 2015 | -126.80% |
| Mar 31, 2015 | 76.47% |
| Dec 31, 2014 | -280.40% |
| Sep 30, 2014 | 77.62% |
| Jun 30, 2014 | 79.38% |
| Mar 31, 2014 | -1,048.15% |